ミカムロBP治験への追加オプション

基本情報

NCT ID: NCT01975246
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 309
治験依頼者名: Boehringer Ingelheim

概要

This is a multi-centre, randomised, double-blind, active-controlled, parallel-group comparative trial to compare the fixed dose combination (FDC) of telmisartan 80 mg +hydrochlorothiazide 12.5 mg and amlodipine 5 mg (T80/A5/H12.5 mg) to telmisartan 80 mg+ amlodipine 5 mg (T80/A5 mg) in blood pressure lowering effect at week 8, the end of the double-blind period in essential hypertensive patients who fail to respond adequately to telmisartan 80 mg+ amlodipine 5 mg. Patients are assigned to one of the two groups after a 6-week open-label run-in period taking T80/A5 mg.

対象疾患

Hypertension

介入

Telmisartan + amlodipine(DRUG)

hydrochlorothiazide(DRUG)

Telmisartan + amlodipine(DRUG)

Placebo(DRUG)

依頼者（Sponsor）

日本ベーリンガーインゲルハイム株式会社(INDUSTRY)

実施施設 (30)

1348.1.013 Boehringer Ingelheim Investigational Site

Naka-ku,Yokohama,Kanagawa, Japan

1348.1.007 Boehringer Ingelheim Investigational Site

Okinawa, Okinawa, Japan

1348.1.026 Boehringer Ingelheim Investigational Site

Sapporo, Hokkaido, Japan

1348.1.031 Boehringer Ingelheim Investigational Site

Chiyoda-ku, Tokyo, Japan

1348.1.008 Boehringer Ingelheim Investigational Site

Suita, Osaka, Japan

1348.1.021 Boehringer Ingelheim Investigational Site

Chuo-ku,Tokyo, Japan

1348.1.001 Boehringer Ingelheim Investigational Site

Kishiwada, Osaka, Japan

1348.1.004 Boehringer Ingelheim Investigational Site

Miyagino-ku, Sendai, Miyagi, Japan

1348.1.014 Boehringer Ingelheim Investigational Site

Kiyose,Tokyo, Japan

1348.1.028 Boehringer Ingelheim Investigational Site

Itoshima, Fukuoka, Japan

1348.1.020 Boehringer Ingelheim Investigational Site

Sakaide, Kagawa, Japan

1348.1.030 Boehringer Ingelheim Investigational Site

Chuo-ku, Tokyo, Japan

1348.1.009 Boehringer Ingelheim Investigational Site

Kita-ku, Osaka, Japan

1348.1.005 Boehringer Ingelheim Investigational Site

Chiyoda-ku, Tokyo, Japan

1348.1.022 Boehringer Ingelheim Investigational Site

Mihama-ku, Chiba, Chiba, Japan

1348.1.002 Boehringer Ingelheim Investigational Site

Chiyoda-ku, Tokyo, Japan

1348.1.018 Boehringer Ingelheim Investigational Site

Nishi-ku, Fukuoka, Fukuoka, Japan

1348.1.003 Boehringer Ingelheim Investigational Site

Koto-ku, Tokyo, Japan

1348.1.029 Boehringer Ingelheim Investigational Site

Kita-ku, Osaka, Japan

1348.1.019 Boehringer Ingelheim Investigational Site

Takamatsu, Kagawa, Japan

1348.1.033 Boehringer Ingelheim Investigational Site

Chuo-ku, Tokyo, Japan

1348.1.032 Boehringer Ingelheim Investigational Site

Suita, Osaka, Japan

1348.1.023 Boehringer Ingelheim Investigational Site

Toshima-ku, Tokyo, Japan

1348.1.016 Boehringer Ingelheim Investigational Site

Chuo-ku,Sapporo,Hokkaido, Japan

1348.1.006 Boehringer Ingelheim Investigational Site

Bunkyo-ku, Tokyo, Japan

1348.1.024 Boehringer Ingelheim Investigational Site

Itabashi-ku, Tokyo, Japan

1348.1.027 Boehringer Ingelheim Investigational Site

Katsushika-ku, Tokyo, Japan

1348.1.025 Boehringer Ingelheim Investigational Site

Sapporo, Hokkaido, Japan

1348.1.017 Boehringer Ingelheim Investigational Site

Moriya, Ibaraki, Japan

1348.1.015 Boehringer Ingelheim Investigational Site

Atsubetsu-ku,Sapporo,Hokkaido, Japan